+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tendinopathy - Epidemiology Forecast to 2030

  • ID: 5387725
  • Drug Pipelines
  • July 2021
  • Region: Global
  • 60 pages
  • DelveInsight
This ‘Tendinopathy - Epidemiology Forecast-2030' report delivers an in-depth understanding of Tendinopathy, historical and forecasted epidemiology as well as the Tendinopathy trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Tendinopathy Disease Understanding

Tendinopathy is an umbrella term for diseases of the tendons - fibrous cords of tissue that hold muscles to bone. Although tendons must be strong and flexible to do their job, they can be injured due to overuse. Tendinopathy broadly refers to three varieties of tendon injury and is often confused with or used synonymously with them. They are as follows:
  • Tendonitis/tendinitis: Inflammation of a tendon, usually due to acute injury caused by overuse or repetitive strain
  • Tendinosis: Chronic tendon injury with little or no inflammation involving micro-tears in the affected tendon. Tendinosis causes long-term pain and is degenerative
  • Paratenonitis: Inflammation of the outer sheath (paratenon) that surrounds certain tendons, such as the Achilles
All of these conditions increase the risk of a more serious tendon tear or rupture
Tendons are “mechanical bridges”; they are strong fibrous structures of pearly color that connect the muscles to the bones, and their primary function is of transforming the force generated by muscle contraction into movement. In addition to this, they can absorb external forces to limit muscle overloads and act as temporary energy storage devices. Due to their proprioceptive properties, tendons are also of primary importance in postural adjustments.

Tendinopathy Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Cases of Tendinopathy, Gender-specific Incident Cases of Tendinopathy, Type-specific Incident Cases of Tendinopathy, and Region-specific Incident Cases of Tendinopathy scenario in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2018 to 2030.

Tendinopathy Detailed Epidemiology Segmentation
  • In 2020, the total incident cases of Tendinopathy were found out to be 29,282,773 in the 7MM.
  • Tendinopathy incidence for the United States has shown an increasing trend. As per the estimates, the United States accounted for 11,920,169 incident cases in 2020 and is estimated to increase in 2030.
  • Among the European 5 countries, France had the highest incident population of Tendinopathy with 4,450,554 cases, followed by the UK and Italy, in 2020. On the other hand, Spain had the lowest incident population of 416,722 in 2020.
  • The Incident Cases of Tendinopathy are on the rise, and it is estimated that Japan accounted for 4,973,588 incident cases in 2020.
  • In 2020, a higher number of males were affected by this disease, of the total incident population of the United States, which is equivalent to 8,344,118 cases in the male population of the country. In comparison to this, for females, the number of cases was observed to be 3,576,051 in 2020.
Scope of the Report
  • The report covers the descriptive overview of Tendinopathy, explaining its causes, symptoms, pathophysiology, and genetic basis.
  • The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The report assesses the disease risk and burden and highlights the unmet needs of Tendinopathy.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for 7MM by Total Incident Cases of Tendinopathy, Gender-specific Incident Cases of Tendinopathy, Type-specific Incident Cases of Tendinopathy, and Region-specific Incident Cases of Tendinopathy.
Report Highlights
  • 10-Year Forecast of Tendinopathy
  • 7MM Coverage
  • Total Incident Cases of Tendinopathy
  • Gender-specific Incident Cases of Tendinopathy
  • Type-specific Incident Cases of Tendinopathy
  • Region-specific Incident Cases of Tendinopathy
Key Questions Answered
  • What are the disease risk, and burden of Tendinopathy?
  • What is the historical Tendinopathy patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
  • What would be the forecasted patient pool of Tendinopathy at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Tendinopathy?
  • Out of the above-mentioned countries, which country would have the highest incident population of Tendinopathy during the forecast period (2021-2030)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2021-2030)?
Reasons to Buy

The Tendinopathy report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the 7MM Tendinopathy epidemiology forecast.
  • The Tendinopathy epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Tendinopathy epidemiology model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.
Key Assessments
  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
Geographies Covered
  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
Study Period: 2018-2030
Note: Product cover images may vary from those shown
1 Key Insights

2 Report Introduction

3 Executive Summary of Tendinopathy

4 Disease Background and Overview
4.1 Introduction
4.2 Classification
4.3 Causes
4.4 Signs and Symptoms
4.5 Risk factors
4.5.1 Sports
4.5.2 Occupation
4.5.3 Genetic factors
4.6 Histopathological changes
4.7 Pathophysiology
4.7.1 Mechanical Theory
4.7.2 Inflammation Theory
4.7.3 Apoptosis Theory
4.7.4 Vascular or neurogenic theory
4.7.5 Continuum model
4.8 Molecular Mechanism
4.9 Biomarkers
4.10 Diagnosis
4.10.1 Screening
4.10.2 Victorian Insitute of Sports Assessment (VISA)
4.11 Differential Diagnosis
4.12 Diagnostic Guidelines

5 Epidemiology and Patient Population
5.1 Key Findings
5.2 Epidemiology Methodology
5.3 Total Incident Cases of Tendinopathy in the 7MM
5.4 Epidemiology of Tendinopathy
5.5 The United States
5.5.1 Total Incident Cases of Tendinopathy in the United States
5.5.2 Gender-specific Incident Cases of Tendinopathy in the United States
5.5.3 Type-specific Incident Cases of Tendinopathy in the United States
5.5.4 Region-specific Incident Cases of Tendinopathy in the United States
5.6 EU5
5.6.1 Germany
5.6.1.1 Total Incident Cases of Tendinopathy in Germany
5.6.1.2 Gender-specific Incidence of Tendinopathy in Germany
5.6.1.3 Type-specific Incident Cases of Tendinopathy in Germany
5.6.1.4 Region-Specific Incident Cases of Tendinopathy in Germany
5.6.2 France
5.6.2.1 Total Incident Cases of Tendinopathy in France
5.6.2.2 Gender-specific Incident Cases of Tendinopathy in France
5.6.2.3 Type-specific Incident Cases of Tendinopathy in France
5.6.2.4 Region-specific Incident Cases of Tendinopathy in France
5.6.3 Italy
5.6.3.1 Total Incident Cases of Tendinopathy in Italy
5.6.3.2 Gender-specific Incident Cases of Tendinopathy in Italy
5.6.3.3 Type-specific Incident Cases of Tendinopathy in Italy
5.6.3.4 Region-specific Incident of Tendinopathy in Italy
5.6.4 Spain
5.6.4.1 Total Incident Cases of Tendinopathy in Spain
5.6.4.2 Gender-specific Incident Cases of Tendinopathy in Spain
5.6.4.3 Type-specific Incident Cases of Tendinopathy in Spain
5.6.4.4 Region-specific Incident Cases of Tendinopathy in Spain
5.6.5 United Kingdom
5.6.5.1 Total Incident Cases of Tendinopathy in the United Kingdom
5.6.5.2 Gender-specific Incident Cases of Tendinopathy in the United Kingdom
5.6.5.3 Type-specific Incident Population of Tendinopathy in the United Kingdom
5.6.5.4 Region-specific Incident Cases of Tendinopathy in the United Kingdom
5.7 Japan
5.7.1 Total Incident Cases of Tendinopathy in Japan
5.7.2 Gender-specific Incident Cases of Tendinopathy in Japan
5.7.3 Type-specific Incident Cases of Tendinopathy in Japan
5.7.4 Region-specific Incident Cases of Tendinopathy in Japan

6 KOL Views

7 Appendix
7.1 Bibliography
7.2 Report Methodology

8 Publisher Capabilities

9 Disclaimer

10 About the Publisher

List of Tables
Table 1: Summary of Tendinopathy Epidemiology, and Key Events (2018-2030)
Table 2: Common sites of overuse tendon injuries
Table 3: Histopathological classification of tendon disorders
Table 4: Comparison of the normal and tendinopathic tendon by macroscopic, light, and electron microscopic and ultrasound findings
Table 5: Tests to aid in the diagnosis of tendinopathy
Table 6: Differential diagnosis of tendinopathy
Table 7: Recommendations for managing tendinopathy
Table 8: Key Recommendations for practice
Table 9: Pain Reduction and Load Management
Table 10: Isotonic Loading Progression
Table 11: Energy Storage Loading Progression (Plyometrics)
Table 12: Return to Sport/Activity
Table 13: Total Incident Cases of Tendinopathy in the 7MM, in Thousand (2018-2030)
Table 14: Total Incident Cases of Tendinopathy in the United States, in Thousand (2018-2030)
Table 15: Gender-specific Incident Cases of Tendinopathy in the US, in Thousand (2018-2030)
Table 16: Type-specific Incident Cases of Tendinopathy in the US, in Thousand (2018-2030)
Table 17: Region-specific Incident Cases of Tendinopathy in the United States, in Thousand (2018-2030)
Table 18: Total Incident Cases of Tendinopathy in Germany, in Thousands (2018-2030)
Table 19: Gender-specific Incident Cases of Tendinopathy in Germany, in Thousand (2018-2030)
Table 20: Type-specific Incident Cases of Tendinopathy in Germany, in Thousand (2018-2030)
Table 21: Region-specific Incident Cases of Tendinopathy in Germany, in Thousand (2018-2030)
Table 22: Total Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Table 23: Gender-specific Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Table 24: Type-specific Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Table 25: Region-specific Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Table 26: Total Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Table 27: Gender-specific Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Table 28: Type-specific Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Table 29: Region-specific Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Table 30: Total Incident Cases of Tendinopathy in Spain, in Thousand (2018-2030)
Table 31: Gender-specific Incident Cases of Tendinopathy in Spain, in Thousand (2018-2030)
Table 32: Type-specific Incident Cases of Tendinopathy in Spain, in Thousand (2018-2030)
Table 33: Region-specific Incident Cases of tendinopathy in Spain, in Thousand (2018-2030)
Table 34: Total Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Table 35: Gender-specific Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Table 36: Type-specific Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Table 37: Region-specific Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Table 38: Total Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Table 39: Gender-specific Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Table 40: Type-specific Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Table 41: Region-specific Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)

List of Figures
Figure 1: Healthy Tendon vs. Tendon in Tendinopathy
Figure 2: Classification of Tendinopathy
Figure 3: Pathophysiology of tendinopathy
Figure 4: Molecular Mechanisms of Tendinopathy
Figure 5: Management of Tendinopathy
Figure 6: Total Incident Cases of Tendinopathy in the 7MM, in Thousand (2018-2030)
Figure 7: Total Incident Cases of Tendinopathy in the United States, in Thousand (2018-2030)
Figure 8: Gender-specific Incident Cases of Tendinopathy in the US, in Thousand (2018-2030)
Figure 9: Type-specific Incident Cases of Tendinopathy in the US, in Thousand (2018-2030)
Figure 10: Region-specific Incident Cases of Tendinopathy in the United States, in Thousand (2018-2030)
Figure 11: Total Incident Cases of Tendinopathy in Germany, in Thousands (2018-2030)
Figure 12: Gender-specific Incident Cases of Tendinopathy in Germany, in Thousand (2018-2030)
Figure 13: Type-specific Incident Cases of Tendinopathy in Germany, in Thousand (2018-2030)
Figure 14: Region-specific Incident Cases Tendinopathy in Germany, in Thousand (2018-2030)
Figure 15: Total Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Figure 16: Gender-specific Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Figure 17: Type-specific Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Figure 18: Region-specific Incident Cases of Tendinopathy in France, in Thousand (2018-2030)
Figure 19: Total Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Figure 20: Gender-specific Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Figure 21: Type-specific Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Figure 22: Region-specific Incident Cases of Tendinopathy in Italy, in Thousand (2018-2030)
Figure 23: Total Incident Cases of Tendinopathy in Spain, in Thousand (2018-2030)
Figure 24: Gender-specific Incident Cases of Tendinopathy in Spain, in Thousand (2018-2030)
Figure 25: Type-specific Incident Cases of Tendinopathy in Spain, in Thousand (2018-2030)
Figure 26: Region-specific Incident Cases of tendinopathy in Spain, in Thousand (2018-2030)
Figure 27: Total Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Figure 28: Gender-specific Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Figure 29: Type-specific Incident Population of Tendinopathy in the UK, in Thousand (2018-2030)
Figure 30: Region-specific Incident Cases of Tendinopathy in the UK, in Thousand (2018-2030)
Figure 31: Total Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Figure 32: Gender-specific Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Figure 33: Type-specific Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Figure 34: Region-specific Incident Cases of Tendinopathy in Japan, in Thousand (2018-2030)
Note: Product cover images may vary from those shown
Adroll
adroll